Episode 120: How to Build Smart Early-Stage Biotech Partnerships That Actually Work
Trying to form early biotech partnerships but unsure when to say yes, when to push back, or when to walk away?
In this episode, host Elaine Hamm, PhD, welcomes back Renee Williams, PhD, MBA, returning to the show as Chief Business Officer at Signify Bio. Drawing from her experience on both sides of the table (as a pharma dealmaker and now an early-stage biotech leader) Renee shares hard-earned insights on how founders can approach partnerships strategically without losing focus, time, or control of their company’s story.
In this episode, you’ll learn:
- How to evaluate early partnership opportunities and decide which ones are worth your limited time, capital, and attention.
- Why focus is the most valuable currency for early-stage biotech, especially for platform companies facing constant “what else could this do?” questions.
- Practical guidance on MTAs, pilot studies, and proof-of-concept work, including how to structure collaborations so they move you closer to a real deal—not just more experiments.
Whether you’re navigating your first pharma conversation or refining how you partner as a growing biotech company, this episode offers clear, experience-driven advice to help you build partnerships that accelerate progress instead of distracting from it.
Links:
Connect with Renee Williams, PhD, MBA, and check out Signify Bio.
Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.
Check out our previous episode with Renee.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
